During lunch, you may discuss topics of current interest with the researchers identified below. There is a $65 fee to cover the cost of lunch and attendance will be limited to 10 persons per table, including the speaker. Assignments were processed on a first-come, first-served basis.
Title: Table #20: Dental-derived Stem Cell-based Bone Regenerative Therapies
The ultimate goal of bone tissue engineering is the regeneration of a construct that matches the physical and biological properties of the natural bone tissue. Repair and regeneration of craniofacial bone defects has widely been achieved with bone grafting procedures. However, there are several disadvantages associated with this treatment modality. An advantageous alternative therapeutic option is bone regeneration using mesenchymal stem cells (MSCs). MSCs derived from orofacial tissues are attractive postnatal stem cells with self-renewal and multilineage differentiation capacity providing superior osteogenic properties. Furthermore, the neural crest origin of these MSCs makes them a better source for jawbone regeneration. In these series of presentation alternative bone regenerative properties based on concepts of tissue engineering using stem cells and growth factors will be discussed.
- Review the current treatment modality of craniofacial bone tissue regeneration.
- Introduce and discuss the latest developments in periodontal tissue regeneration and bone tissue engineering, using smart biomaterials and growth factors.
- Introduce novel treatment modalities for bone regenerative treatments based on stem cell therapy and tissue engineering concepts as futuristic therapies for patients.
12:30 pm–1:45 pm Mar 23 (US - Eastern)